Dare Bioscience, Inc.Dare Bioscience, Inc.Dare Bioscience, Inc.

Dare Bioscience, Inc.

No trades
See on Supercharts
Market capitalization
‪48.29 M‬USD
−0.3372USD
‪−30.16 M‬USD
‪2.81 M‬USD
‪98.82 M‬
Beta (1Y)
1.23

About Dare Bioscience, Inc.

CEO
Sabrina Martucci Johnson
Headquarters
San Diego
Employees (FY)
26
Founded
2015
ISIN
US23666P1012
FIGI
BBG001J2P362
Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DARE is 0.49 USD — it has increased by 1.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Dare Bioscience, Inc. stocks are traded under the ticker DARE.
Dare Bioscience, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Dare Bioscience, Inc. has a max estimate of 6.00 USD and a min estimate of 2.00 USD.
DARE earnings for the last quarter are −0.09 USD whereas the estimation was −0.10 USD which accounts for 6.99% surprise. Estimated earnings for the next quarter are −0.09 USD. See more details about Dare Bioscience, Inc. earnings.
Dare Bioscience, Inc. revenue for the last quarter amounts to ‪1.00 M‬ USD despite the estimated figure of ‪733.33 K‬ USD. In the next quarter revenue is expected to reach ‪2.38 M‬ USD.
Yes, you can track Dare Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, DARE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dare Bioscience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
DARE reached its all-time high on Mar 19, 2015 with the price of 108.70 USD, and its all-time low was 0.27 USD and was reached on Dec 8, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 26.00 employees. See our rating of the largest employees — is Dare Bioscience, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Dare Bioscience, Inc. EBITDA is ‪−30.81 M‬ USD, and current EBITDA margin is ‪−1.10 K‬%. See more stats in Dare Bioscience, Inc. financial statements.